Glycosphingolipids (GSLs) play essential roles in many important biological processes, making them attractive synthetic targets. In this paper, a viable chemoenzymatic method is described for the synthesis of globo-series GSLs, namely, Gb4, Gb5, SSEA-4, and Globo H. The strategy uses a chemically synthesized lactoside acceptor equipped with a partial ceramide structure that is uniquely extended by glycosyltransferases in a highly efficient one-pot multiple enzyme (OPME) procedure. A direct and quantitative conversion of Gb4 sphingosine to Globo H sphingosine is achieved by performing two-sequential OPME glycosylations. A reduction and N-acylation protocol allows facile incorporation of various fatty acids into the lipid portions of the GSLs. The chemically well-defined lipid-modified Globo H-GSLs displayed some differences in their immunosuppressive activities, which may benefit the structural modifications of Globo H ceramides in finding new types of immunosuppressive agents. The strategy outlined in this work should be applicable to the rapid access to other complex GSLs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/asia.202200403 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ganglioside SSEA-4 in Ewing sarcoma marks a tumor cell population with aggressive features and is a potential cell-surface immune target.
Sci Rep
May 2024
Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer Campus 1, 38149, Muenster, Germany.
Article Synopsis
- Scientists found a special marker called SSEA-4 that shows up on immature cells during pregnancy and is also found in a type of cancer called Ewing sarcoma.
- This marker was present on most cancer cell lines and many tumor samples, and higher levels of SSEA-4 were linked to more aggressive cancer behavior.
- T cells, which are part of our immune system, can be specially trained to target cells with SSEA-4, making it a promising way to treat this type of cancer in the future.
Regulation of Glycosylation in Bone Metabolism.
Int J Mol Sci
March 2024
Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Kasugai 487-8501, Aichi, Japan.
Glycosylation plays a crucial role in the maintenance of homeostasis in the body and at the onset of diseases such as inflammation, neurodegeneration, infection, diabetes, and cancer. It is also involved in bone metabolism. - and -glycans have been shown to regulate osteoblast and osteoclast differentiation.
View Article and Find Full Text PDFIncreased expression of SSEA-4 on TKI-resistant non-small cell lung cancer with EGFR-T790M mutation.
Proc Natl Acad Sci U S A
January 2024
Genomics Research Center, Academia Sinica, Taipei 11529, Taiwan.
Non-small cell lung cancer (NSCLC), a major life-threatening disease accounting for 85% of all lung cancer cases, has been treated with tyrosine kinase inhibitors (TKIs), but often resulted in drug resistance, and approximately 60% of TKI-resistant cases are due to acquired secondary (epithelial growth factor receptor) EGFR-T790M mutation. To identify alternative targets for TKI-resistant NSCLC with EGFR-T790M mutation, we found that the three globo-series glycosphingolipids are increasingly expressed on this type of NSCLC cell lines, and among them, the increase of stage-specific embryonic antigen-4 (SSEA-4) expression is the most significant. Compared to TKI-sensitive cell lines, SSEA-4 and the key enzyme β3GalT5 responsible for the synthesis of SSEA3 are more expressed in TKI-resistant NSCLC cell lines with EGFR-T790M mutation, and the expression levels strongly correlate with poor survival in patients with EGFR mutation.
View Article and Find Full Text PDFGlobo-series Gb4 activates ERK and promotes the proliferation of osteoblasts.
J Oral Biosci
March 2024
Department of Pharmacology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan. Electronic address:
Objectives: Globo-series Gb4 (globoside) is involved in the immune system and disease pathogenesis. We recently reported that systemic Gb4 deficiency in mice led to decreased bone formation due to a reduction in osteoblast number. However, it remains unclear whether Gb4 expressed in osteoblasts promotes their proliferation.
View Article and Find Full Text PDFNeural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
Hum Mol Genet
December 2023
Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, United States.
GM3 Synthase Deficiency (GM3SD) is a neurodevelopmental disorder resulting from pathogenic variants in the ST3GAL5 gene, which encodes GM3 synthase, a glycosphingolipid (GSL)-specific sialyltransferase. This enzyme adds a sialic acid to the terminal galactose of lactosylceramide (LacCer) to produce the monosialylated ganglioside GM3. In turn, GM3 is extended by other glycosyltransferases to generate nearly all the complex gangliosides enriched in neural tissue.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!